Literature DB >> 6196341

A possible new HLA-DR allele.

H Betuel, L Gebuhrer, J Lambert, A C Freidel, A Farre.   

Abstract

In routine screening of anti-HLA DR reagents, serum 901 was obtained from a woman of negroid origin ten days after delivery of a second child. The spouse was also of black origin. This serum contained polyspecific HLA A and B antibodies. After platelet absorption it reacted with the B cells of 10 out of 119 European Caucasoid panel donors (8.4%) typed for DR1 to DRW10 and for MT1, MT2. Each of these ten donors had only one recognized DR antigen, the other was "blank." Serum 901 gave negative reactions with the homozygous typing cells (HTC) DW1 to DW8. In 18 normal informative Caucasoid families, serum 901 recognized one HLA haplotype in one (or both) parents and segregated with this haplotype in one or more than one child. In one family in which both parents reacted with serum 901, two children were homozygous for this marker and reacted as HTCs. One of these HTCs typed as DW9 and was found to be identical to a DW9.HTC (8W207).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196341     DOI: 10.1016/0198-8859(83)90040-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

Review 1.  Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a 10 year experience.

Authors:  M G Forest; M David
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

Review 2.  Prenatal treatment of congenital adrenal hyperplasia: report of a new case.

Authors:  G A Loeuille; M David; M G Forest
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

3.  Functional definition of HLA-DR and -DQ epitopes specific for DR2-short, DwFJO haplotype.

Authors:  D Zeliszewski; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.

Authors:  G Sterkers; D Zeliszewski; A M Chaussée; I Deschamps; M P Font; C Freidel; J Hors; H Betuel; J Dausset; J P Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy.

Authors:  A Marcadet; L Gebuhrer; H Betuel; J Seignalet; A C Freidel; C Confavreux; M Billiard; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms.

Authors:  M P Font; L Gebuhrer; H Betuel; C Freidel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia.

Authors:  Y Morel; J André; B Uring-Lambert; G Hauptmann; H Bétuel; M Tossi; M G Forest; M David; J Bertrand; W L Miller
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  HLA-DR2 negative narcolepsy.

Authors:  C Confavreux; L Gebuhrer; H Betuel; C Freidel; H Bastuji; G Aimard; M Devic; M Jouvet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

9.  An antiviral T-cell clone defines a functional supertypic specificity shared by different HLA-DR molecules from DR2-short, DRw11, and DRw13 haplotypes.

Authors:  D Zeliszewski; G Sterkers; J Choppin; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.

Authors:  H Plotnicky; J L Touraine
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.